This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.
PFENegative Net Change MRNANegative Net Change BYDPositive Net Change NVAXNegative Net Change SCVLPositive Net Change
consumer-discretionary medical pharmaceuticals retail
J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
by Zacks Equity Research
JNJ halts Imaavy's rheumatoid arthritis program after trial results showed no added benefit over existing therapy.
JNJPositive Net Change ANIPPositive Net Change CRMDNegative Net Change
biotechs medical pharmaceuticals
OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
by Zacks Equity Research
Outlook Therapeutics stock plunges 54% after the FDA rejects ONS-5010 BLA again, citing lack of efficacy data in confirmatory study.
CRMDNegative Net Change KNSANegative Net Change OTLKNegative Net Change PHARPositive Net Change
biotechnology biotechs medical pharmaceuticals
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?
by Sridatri Sarkar
As the structural heart market expands, Abbott and Edwards battle for leadership. Which stock holds stronger growth momentum now?
ABTPositive Net Change EWPositive Net Change
medical
COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down
by Zacks Equity Research
Cooper Companies beats on Q3 earnings with 15% EPS growth, but revenue weakness and a trimmed 2025 outlook send shares tumbling.
BSXPositive Net Change COONegative Net Change WSTNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Here's Why You Should Add CLOV Stock to Your Portfolio Now
by Zacks Equity Research
Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change CLOVPositive Net Change
medical medical-devices
4 Stocks Trading Near 52-Week High With Room to Rise Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run. Stocks like POST, MD, NVST and ZION are seeing price strength, and the momentum is likely to continue.
ZIONPositive Net Change MDNegative Net Change POSTNegative Net Change NVSTNegative Net Change
consumer-staples finance medical
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
by Sundeep Ganoria
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
ACBNegative Net Change GTBIFNegative Net Change VRNOFPositive Net Change CURLFPositive Net Change
marijuana medical
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
by Moumi Mondal
HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.
BSXPositive Net Change HOLXNegative Net Change QGENNegative Net Change
medical medical-devices
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
by Zacks Equity Research
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
ANegative Net Change PAHCPositive Net Change SNDXPositive Net Change ASTHPositive Net Change
earnings medical medical-devices
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
by Zacks Equity Research
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
HUMNegative Net Change THCPositive Net Change AVDLNegative Net Change INFUPositive Net Change
insurance medical smart-health
Are Options Traders Betting on a Big Move in Becton Dickinson Stock?
by Zacks Equity Research
Investors need to pay close attention to Becton Dickinson stock based on the movements in the options market lately.
BDXNegative Net Change
medical medical-devices
FDA Approves Updated COVID-19 Vaccines but With Restrictions
by Zacks Equity Research
FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.
PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change
biotechs medical messenger-rna vaccines
VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up
by Zacks Equity Research
Veeva Systems' second-quarter earnings and revenues beat estimates, margins expand and raised FY26 outlook lifts shares higher.
BSXPositive Net Change WSTNegative Net Change VEEVNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?
by Ahan Chakraborty
ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.
ALNYPositive Net Change PFENegative Net Change BBIONegative Net Change
biotechnology biotechs medical pharmaceuticals
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?
by Debanjana Dey
Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.
AMWLNegative Net Change HIMSPositive Net Change
medical medical-devices
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
by Zacks Equity Research
Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.
INONegative Net Change CRMDNegative Net Change KNSANegative Net Change PGENNegative Net Change
biotechnology biotechs medical pharmaceuticals
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
by Vasundhara Sawalka
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, HWM, COR and CAKE are some such stocks.
GEPositive Net Change CAKENegative Net Change CORPositive Net Change HWMPositive Net Change
aerospace medical retail
DGX Stock Gains Following a New Joint Venture With Corewell Health
by Zacks Equity Research
Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.
BSXPositive Net Change DGXPositive Net Change IDXXNegative Net Change NVSTNegative Net Change
medical
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?
by Zacks Equity Research
TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.
BSXPositive Net Change TMONegative Net Change PAHCPositive Net Change NVSTNegative Net Change
medical
CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?
by Sundeep Ganoria
CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.
VRTXPositive Net Change BEAMNegative Net Change CRSPNegative Net Change
biotechs crispr gene-editing gene-therapy medical pharmaceuticals
ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?
by Indrajit Bandyopadhyay
ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.
MDTPositive Net Change ISRGPositive Net Change
medical medical-devices
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
by Zacks Equity Research
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
BSXPositive Net Change PAHCPositive Net Change MEDPNegative Net Change WGSNegative Net Change
earnings medical medical-devices
Should You Add Zimmer Biomet Stock to Your Portfolio Now?
by Zacks Equity Research
ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.
BSXPositive Net Change CAHPositive Net Change ZBHNegative Net Change NVSTNegative Net Change
medical medical-devices
Top Analyst Reports for Berkshire Hathaway, Toyota Motor & McDonald's
by Mark Vickery
Analysts spotlight Berkshire, Toyota and McDonald's, highlighting growth drivers, risks and market performance in new research reports.
TMPositive Net Change MCDPositive Net Change BRK.BPositive Net Change ELTPNegative Net Change BKTINegative Net Change
auto-tires-trucks computers insurance medical restaurants